AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hannover Rueck SE

Investor Presentation Nov 4, 2020

197_ip_2020-11-04_6f5d4466-1bca-4d64-84dc-60d7e4cdd09f.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Conference Call on Q3/2020 financial results

Hannover, 4 November 2020

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 17
6 Appendix 22

Favourable result in spite of reserving for Covid-19 loss estimates Double-digit premium growth driven by improving market conditions

Very strong operating cash flow driven by profitable premium growth AuM +2.8%, cash flow and increasing valuation reserves overcompensate f/x effects

Shareholders' equity up by +2.8% Dividend payment in Q2 fully covered by 9-month earnings, OCI increased

2
Property & Casualty reinsurance
3
Life & Health reinsurance
Investments
4
Outlook
5
6
Appendix
2
6
11
14
17
22

Double-digit growth in an improving market environment Underwriting result impacted by reserving for Covid-19 loss estimates

Property & Casualty R/I in m. EUR Q3/2019 Q3/2020 Q1-3/2019 Q1-3/2020
Gross written premium 3,806 4,173 11,653 13,348
Net premium earned 3,318 3,643 9,282 10,512
Net underwriting result
incl. funds withheld
(70) 15 125 (146)
Combined ratio
incl. interest on funds withheld
102.1% 99.6% 98.6% 101.4%
Net investment income from
assets under own management
292 234 768 667
Other income and expenses 40 50 26 67
Operating profit/loss (EBIT) 262 299 919 589
Tax ratio 8.3% 35.4% 23.6% 25.2%
Group net income 209 173 640 418
Earnings per share (in EUR) 1.73 1.44 5.31 3.47

YTD

  • GWP f/x-adjusted +15.9%
  • NPE f/x-adjusted +14.7%
  • Major losses of EUR 1,149 m. (10.9% of NPE) exceeded budget of EUR 749 m. for Q1-3/2020 due to reserving for Covid-19 loss estimates (EUR 700 m.); combined ratio adjusted for above-budget losses at 97.6% for Q1-3/2020
  • Realised gains mitigate lower ordinary investment income and moderate impairments for private equity
  • Other income and expenses increased mainly due to positive currency effects
  • EBIT margin of 5.6% below target of 10%

Major losses including Covid-19 reserving exceed Q1-3/2020 budget of EUR 749 m. by EUR 400 m.

Overall moderate major-loss expenditure apart from Covid-19-related losses, despite increased large-loss activity in Q3/2020 Catastrophe losses1 ) in m. EUR Date Gross Net

Bushfire, Australia 1 - 31 Jan 29.2 28.9
Earthquake, Puerto Rico 6 - 7 Jan 17.5 14.5
Hail, Australia 15 - 21 Jan 12.6 7.3
Hail / Storm, Australia 19 - 20 Jan 25.2 17.4
Storm / Flood, Australia 4 - 13 Feb 21.5 13.8
Storm "Sabine", Europe 9 - 11 Feb 26.5 20.2
Tornados, USA 2 - 5 Mar 50.8 40.0
Hail / Storm, Australia 19 - 20 Apr 13.3 9.4
Floods, China 22 May - 22 Jul 29.0 29.0
Hail / Storm, Canada 13 - 14 Jun 35.2 20.9
Floods, Japan 3 - 6 Jul 11.0 10.0
Hail / Storm, USA 6 - 12 Aug 116.7 83.9
California wildfire, USA 16 Aug - 18 Sep 11.1 7.9
Hurricane "Laura", USA 26 - 29 Aug 92.9 64.4
14 Natural catastrophes 492.4 367.4
2 Property losses 84.4 81.6
2 Man-made losses 84.4 81.6
16 Major losses 576.8 449.0
Covid-19-related losses 872.8 700.3
Total 1,449.6 1,149.3

1) Natural catastrophes and other major losses in excess of EUR 10 m. gross Large loss budget 2020: EUR 975 m. thereof EUR 200 m. man-made and EUR 775 m. NatCat

Combined ratio above target due to reserving for Covid-19-related loss estimates

Q1-3/2020: Combined Ratio vs. Target Combined Ratio

1) All lines of Property & Casualty reinsurance except those stated separately

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 17
6 Appendix 22

Good underlying result impacted by Covid-19 losses

Strong contribution from Financial Solutions; Investment income supported by one-off

Life & Health R/I in m. EUR Q3/2019 Q3/2020 Q1-3/2019 Q1-3/2020
Gross written premium 1,894 1,975 5,740 5,947
Net premium earned 1,717 1,751 5,109 5,259
Net underwriting result
incl. funds withheld
(20) (124) (159) (293)
Net investment income from
assets under own management
119 129 414 352
Other income and expenses 93 96 222 257
Operating profit/loss (EBIT) 192 101 478 315
EBIT margin 11.2% 5.8% 9.4% 6.0%
Tax ratio 23.8% (7.1%) 15.1% 5.3%
Group net income 145 108 403 297
Earnings per share (in EUR) 1.20 0.90 3.34 2.46

YTD

  • GWP f/x-adjusted +5.0%
  • NPE f/x-adjusted growth +4.4%
  • Technical result impacted by Covid-19 losses of EUR 160 m., US mortality otherwise in line with expectations
  • Favourable ordinary investment income and change in fair value of financial instruments. Net investment income decreased due to one-off effect in Q2/2019 (EUR 99.5 m.), partly offset by extraordinary valuation gain from at-equity participation in Q3/2020 (EUR 55.2 m.)
  • Other income and expenses mainly the result of strong contribution from deposit accounted treaties of EUR 253 m. (Q1-3/2019: EUR 211 m.)
  • High share of earnings in low-tax subsidiaries and tax-reduced investment gains

Strong new business production across all lines of business Q3/2020 new and pipeline business1)

1) Focus on most important deals and opportunities

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 17

Ordinary income decreasing in line with expectations Supporting realisations mainly from fixed-income sales

in m. EUR Q3/2019 Q3/2020 Q1-3/2019 Q1-3/2020 RoI
Ordinary investment income1) 349 370 1,051 984 2.7%
Realised gains/losses 72 52 200 192 0.5%
Impairments/appreciations & depreciations (12) (16) (53) (102) -0.3%
Change in fair value of financial
instruments (through P&L)
33 (9) 77 41 0.1%
Investment expenses (30) (33) (90) (95) -0.3%
NII from assets under own management 412 364 1,184 1,021 2.8%
NII from funds withheld 54 28 148 164
Total net investment income 466 392 1,332 1,185
Unrealised gains/losses of investments 31 Dec 19 30 Sep 20
On-balance sheet 1,789 2,686
thereof Fixed income AFS 1,356 2,208
Off-balance sheet 524 539
thereof Fixed income HTM, L&R 233 222
Total 2,314 3,225

1) Incl. results from associated companies

• Decreasing ordinary income mainly due to inflation linkers within fixedincome securities as well as lower returns from private equity and opportunistic real estate funds; rather stable results from direct real estates; positive one-off effect from at-equity consolidation of Life & Health participations

YTD

  • Realised gains mainly driven by some reallocations within fixedincome portfolio and regular portfolio adjustments as well as the disposals of real estate investments; prior year benefitted from Life & Health one-off effect
  • Higher impairments predominantly driven by increased portion of private equity and opportunistic real estate fund valuations; additional impairment on two issuers of fixed-income securities mainly recognised on emerging markets government bonds; stable depreciation on direct real estate investments
  • Rise in valuation reserves due to significantly decreasing risk-minimal yield curves overcompensating widening of credit spreads on corporates and lower valuations in the alternative spectrum

Ordinary return supported by alternative assets

Credit profile slightly more defensive; modest re-entry into listed equities in Q1

1)

Investment category 2016 2017 2018 2019 Q3/2020
Fixed-income securities 87% 87% 87% 87% 86%
- Governments 28% 30% 35% 35% 35%
- Semi-governments 18% 17% 16% 15% 15%
- Corporates 33% 32% 29% 31% 29%
Investment grade 28% 27% 25% 26% 25%
Non-investment grade 4% 5% 4% 4% 4%
- Pfandbriefe, Covered bonds, ABS 9% 8% 7% 7% 2)
6%
Equities 4% 2% 2% 3% 3%
- Listed equity 2% <1% <1% <1% 1%
- Private equity 2% 2% 2% 2% 3%
Real Assets 5% 5% 6% 5% 5%
Others 1% 1% 1% 2% 2%
Short-term investments & cash 4% 4% 4% 3% 4%
Total market values in bn. EUR 42.3 40.5 42.7 48.2 49.5

Asset allocation Ordinary income split

1) Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments of EUR 1,340.8 m. (EUR 1,429.9 m.) as at 30 September 2020

2) Of which Pfandbriefe and Covered Bonds = 67.5%

3) Before real estate-specific costs. Economic view based on market values as at 30 September 2020

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 17
6 Appendix 22

Updated guidance for 2020

Hannover Re Group

Gross written premium1) growth in the upper single-digit percentage range
Return on investment2) 3) ~ 2.7%
Group net income2) > EUR 800 m.
Ordinary dividend EUR 4 per share

• Special dividend depending on emerging business opportunities and corresponding capital requirements

1) At unchanged f/x rates

2) Subject to no major distortions in capital markets and/or major losses in Q4/2020 not exceeding the large loss budget of EUR 226 m.

3) Excluding effects from ModCo derivatives

| 1 | 2 | 3 | 4 | 5 Outlook | 6 |

Reporting categories Volume1 ) Profitability2 ) Profitability impacted by reserving for Covid-19 loss estimates P&C financial year 2020

Regional EMEA3
)
-
markets Americas3
)
-
APAC3
)
+/-
Structured Reinsurance and ILS +/-
Credit, Surety and Political Risks -
Worldwide
markets
Facultative Reinsurance +
Aviation and Marine +
Agricultural Risks -

1) In EUR, development in original currencies can be different

2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)

3) All lines of business except those stated separately

Profitability in Mortality & Morbidity impacted by Covid-19; FinSol unaffected L&H financial year 2020 Reporting categories Volume1 ) Profitability2 )

Financial solutions ++
Longevity +
Mortality -
Morbidity -

1) In EUR, development in original currencies can be different

2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)

Guidance for 2021

Hannover Re Group

Gross written premium1) ~ 5% growth
Return on investment2) 3) ~ 2.4%
Group net income2) EUR 1.15 -
1.25 bn.
Ordinary dividend pay-out ratio4) 35% -
45%

• Special dividend additional pay-out if profit target is reached and capitalisation is comfortable

1) At unchanged f/x rates

2) Subject to no major distortions in capital markets and/or major losses in 2021 not exceeding the large loss budget of EUR 1,1 bn. and no material Covid-19 impact in L&H

3) Excluding effects from ModCo derivatives

4) Relative to group net income according to IFRS

6 Appendix 22
5 Outlook 17
4 Investments 14
3 Life & Health reinsurance 11
2 Property & Casualty reinsurance 6
1 Group overview 2

| 1 | 2 | 3 | 4 | 5 | 6 Appendix |

Covid-19 impact is material but manageable Q1-3/2020

Expected P&C Covid-19 claims in m. EUR Expected L&H Covid-19 claims in m. EUR

Group net income impacted by reserving for Covid-19 loss estimates

Group figures in m. EUR Q3/2019 Q3/2020 Δ Q1-3/2019 Q1-3/2020 Δ
Gross written premium 5,699 6,149 +7.9% 17,393 19,295 +10.9%
Net premium earned 5,036 5,394 +7.1% 14,391 15,772 +9.6%
Net underwriting result (145) (137) -5.7% (181) (603) -
- Incl. funds withheld (91) (109) +19.7% (33) (439) -
Net investment income 466 392 -15.9% 1,332 1,185 -11.0%
- From assets under own mgmt. 412 364 -11.7% 1,184 1,021 -13.8%
- From funds withheld 54 28 -48.4% 148 164 +11.0%
Other income and expenses 132 144 +9.3% 245 321 +31.3%
Operating profit/loss (EBIT) 453 399 -11.9% 1,395 903 -35.3%
Financing costs (21) (24) +15.0% (64) (72) +12.5%
Net income before taxes 432 375 -13.2% 1,332 831 -37.6%
Taxes (59) (90) +52.0% (266) (142) -46.6%
Net income 373 285 -23.6% 1,066 690 -35.3%
- Non-controlling interests 32 19 -40.1% 63 22 -65.5%
Group net income 341 265 -22.1% 1,003 668 -33.4%
Retention 90.2% 88.6% 90.5% 90.1%
EBIT margin (EBIT/Net premium earned) 101.8% 102.0% 9.7% 5.7%
Tax ratio 9.0% 7.4% 20.0% 17.1%
Earnings per share (in EUR) 2.82 2.20 8.32 5.54

Our strategic business groups at a glance Q1-3/2020 vs. Q1-3/2019

Property & Casualty R/I Life & Health R/I Total
in m. EUR Q1-3/2019 Q1-3/2020 Q1-3/2019 Q1-3/2020 Q1-3/2019 Q1-3/2020
Gross written premium 11,653 13,348 5,740 5,947 17,393 19,295
Change in GWP - +14.5% - +3.6% - +10.9%
Net premium earned 9,282 10,512 5,109 5,259 14,391 15,772
Net underwriting result 92 (187) (272) (416) (181) (603)
Net underwriting result incl. funds withheld 125 (146) (159) (293) (33) (439)
Net investment income 802 708 528 475 1,332 1,185
From assets under own management 768 667 414 352 1,184 1,021
From funds withheld 34 41 114 123 148 164
Other income and expenses 26 67 222 257 245 321
Operating profit/loss (EBIT) 919 589 478 315 1,395 903
Financing costs (2) (2) (1) (1) (64) (72)
Net income before taxes 917 587 477 314 1,332 831
Taxes (216) (148) (72) (17) (266) (142)
Net income 701 439 405 298 1,066 690
Non-controlling interest 61 21 2 1 63 22
Group net income 640 418 403 297 1,003 668
Retention 90.8% 90.3% 89.9% 89.5% 90.5% 90.1%
Combined ratio (incl. interest on funds withheld) 98.6% 101.4% - - - -
EBIT margin (EBIT / Net premium earned) 9.9% 5.6% 9.4% 6.0% 9.7% 5.7%
Tax ratio 23.6% 25.2% 15.1% 5.3% 20.0% 17.1%
Earnings per share (in EUR) 5.31 3.47 3.34 2.46 8.32 5.54

Our strategic business groups at a glance Q3/2020 vs. Q3/2019

Property & Casualty R/I Life & Health R/I Total
in m. EUR Q3/2019 Q3/2020 Q3/2019 Q3/2020 Q3/2019 Q3/2020
Gross written premium 3,806 4,173 1,894 1,975 5,699 6,149
Change in GWP - +9.7% - +4.3% - +7.9%
Net premium earned 3,318 3,643 1,717 1,751 5,036 5,394
Net underwriting result (81) (1) (63) (136) (145) (137)
Net underwriting result incl. funds withheld (70) 15 (20) (124) (91) (109)
Net investment income 303 250 162 142 466 392
From assets under own management 292 234 119 129 412 364
From funds withheld 11 16 43 12 54 28
Other income and expenses 40 50 93 96 132 144
Operating profit/loss (EBIT) 262 299 192 101 453 399
Financing costs (1) (1) 0 0 (21) (24)
Net income before taxes 262 298 191 101 432 375
Taxes (22) (105) (45) 7 (59) (90)
Net income 240 193 146 108 373 285
Non-controlling interest 31 19 1 0 32 19
Group net income 209 173 145 108 341 265
Retention 89.4% 88.0% 91.8% 89.9% 90.2% 88.6%
Combined ratio (incl. interest on funds withheld) 102.1% 99.6% - - - -
EBIT margin (EBIT / Net premium earned) 7.9% 8.2% 11.2 % 5.8% 9.0% 7.4%
Tax ratio 8.3% 35.4% 23.8% (7.1 %) 13.8% 24.1%
Earnings per share (in EUR) 1.73 1.44 1.20 0.90 2.82 2.20

| 1 | 2 | 3 | 4 | 5 | 6 Appendix |

Stress tests on assets under own management; focus on credit exposures Current credit markets back in a slightly increased volatility mode

Portfolio Scenario Change in market
value
in m. EUR
Change in OCI before
tax
in m. EUR
-10% -160 -160
Equity (listed and private equity) -20% -321 -321
+50 bps -1,235 -1,177
Fixed-income securities +100 bps -2,396 -2,283
Credit spreads +50% -845 -839

As at 30 September 2020

High-quality fixed-income book well balanced

</bbb<>
High-quality fixed-income book well balanced
Geographical allocation mainly in accordance with our broad business diversification
Governments Semi
governments
Corporates Pfandbriefe,
Covered bonds,
ABS
Short-term
investments,
cash
Total
AAA 74% 61% 1
%
60% - 47%
A
A
12% 22% 13% 19% - 14%
A 9
%
7
%
32% 13% - 16%
BBB 4
%
1
%
44% 7
%
- 17%
<bbb< td="">2
%
9
%
11%1
%
-6
%
2
%
9
%
11% 1
%
- 6
%
Total 100% 100% 100% 100% - 100%
Germany 20% 34% 4
%
19% 16% 17%
UK 7
%
2
%
7
%
10% 14% 7
%
France 1
%
1
%
7
%
6
%
0
%
3
%
GIIPS 0
%
1
%
4
%
5
%
0
%
2
%
Rest of Europe 3
%
15% 15% 25% 3
%
10%
USA 47% 13% 31% 14% 17% 33%
Australia 5
%
9
%
7
%
10% 9
%
7
%
Asia 12% 11% 11% 2
%
30% 12%
Rest of World 4
%
15% 14% 11% 11% 10%
Total 100% 100% 100% 100% 100% 100%
Total b/s values in m. EUR 17,573 7,451 13,690 3,033 1,783 43,529

IFRS figures as at 30 September 2020

Currency allocation matches modelled liability profile Strict duration-neutral strategy continued

Currency split of investments

  • Modified duration of fixed-income mainly congruent with liabilities and currencies
  • GBP's higher modified duration predominantly due to life business; EUR driven by hybrid bond issuance
Modified duration
Q3/2020 5.8
2019 5.7
2018 4.8
2017 4.8
2016 5.0

Disclaimer

This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities.

While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-todate, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.

Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements.

This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re.

© Hannover Rück SE. All rights reserved. Hannover Re is the registered service mark of Hannover Rück SE.

Talk to a Data Expert

Have a question? We'll get back to you promptly.